Vimta Labs

Vimta Labs

644.50
+36.00
(5.92%)
Market Cap
2,868.38 Cr
EPS
18.51
PE Ratio
44.60
Dividend Yield
0.16 %
Industry
Healthcare
52 Week High
728.45
52 Week Low
242.05
PB Ratio
7.91
Debt to Equity
0.06
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
656.65
#1 26,459.02
51.59
#1 3,714.20
3.77
#1 496
14.53
41.91
572.55
13,745.09
#1 31.66
2,946.50
10.53
407
32.73
53.48
239.00
5,211.96
-
17.60
#1 49.09
-161
-65.66
34.07
644.50
#4 2,868.38
#3 44.60
#4 322.30
#6 0.22
#3 41
#2 112.87
54.25
67.60
159.16
-
788.04
-22.39
-71
#1 133.33
41.99
9.36
138.47
50.61
0.00
-65.97
37
76.32
39.51
42.48
67.29
493.63
46.84
8.04
0
-85.71
57.57
18.00
26.30
33.09
83.71
-3.26
2
-94.64
46.55
24.85
16.50
-
1.96
40.00
-13
-566.67
46.96
Forecast
Actual
Growth Rate
Revenue Growth
0.22 %
Net Income Growth
-14.94 %
Cash Flow Change
-30.76 %
ROE
-24.97 %
ROCE
-26.21 %
EBITDA Margin (Avg.)
-7.88 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
45
33
59
59
60
62
76
68
75
80
81
79
83
84
68
75
80
76
85
95
Expenses
38
29
43
42
43
45
57
47
51
55
55
56
58
59
50
53
55
51
57
57
EBITDA
7
4
16
17
17
17
19
21
24
25
26
23
25
25
18
23
25
25
29
38
Operating Profit %
11 %
11 %
27 %
28 %
28 %
27 %
25 %
31 %
31 %
30 %
32 %
28 %
30 %
30 %
24 %
29 %
31 %
32 %
33 %
37 %
Depreciation
5
6
6
6
6
6
6
6
7
7
8
8
8
9
9
8
8
8
8
10
Interest
1
1
0
1
1
0
0
0
1
1
1
1
0
0
1
1
1
1
0
1
Profit Before Tax
0
-2
0
11
10
11
13
16
16
17
18
14
17
16
8
14
16
17
20
28
Tax
0
-1
-8
3
3
3
3
4
4
5
5
4
4
4
2
3
4
4
5
6
Net Profit
0
-2
8
8
8
8
10
12
12
12
13
10
13
12
6
10
12
12
15
22
EPS in ₹
0.03
-0.88
3.41
3.65
3.50
3.65
4.41
5.28
5.36
5.45
5.97
4.62
5.73
5.51
2.86
3.61
5.58
5.54
6.88
9.65

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
Total Assets
246
274
307
362
400
Fixed Assets
138
135
169
175
171
Current Assets
96
111
124
164
158
Capital Work in Progress
2
18
0
12
59
Investments
0
0
0
0
0
Other Assets
106
122
138
175
170
Total Liabilities
246
274
307
362
400
Current Liabilities
58
54
48
57
54
Non Current Liabilities
15
26
26
23
26
Total Equity
173
194
234
282
320
Reserve & Surplus
169
190
230
277
315
Share Capital
4
4
4
4
4

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
3
1
5
20
-17
Investing Activities
-21
-32
-38
-57
-76
Operating Activities
24
37
59
88
61
Financing Activities
-1
-5
-17
-11
-2

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
37.46 %
37.46 %
37.46 %
37.46 %
37.46 %
37.46 %
37.46 %
37.25 %
37.24 %
37.23 %
37.01 %
36.98 %
36.92 %
36.89 %
36.89 %
36.76 %
36.70 %
36.67 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.74 %
0.00 %
5.13 %
5.16 %
3.31 %
3.81 %
3.66 %
3.49 %
DIIs
0.00 %
0.00 %
1.29 %
1.48 %
1.48 %
1.48 %
1.48 %
2.13 %
2.14 %
2.13 %
1.50 %
1.49 %
1.50 %
1.49 %
0.00 %
1.16 %
1.43 %
1.42 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.08 %
29.45 %
28.48 %
27.35 %
27.07 %
26.99 %
26.79 %
25.06 %
25.19 %
24.60 %
25.00 %
25.15 %
23.08 %
23.13 %
26.53 %
25.09 %
25.17 %
24.02 %
Others
33.46 %
33.09 %
32.77 %
33.71 %
34.00 %
34.07 %
34.27 %
35.56 %
35.43 %
36.04 %
33.75 %
36.38 %
33.37 %
33.33 %
33.27 %
33.18 %
33.03 %
34.40 %
No of Share Holders
12,152
20,928
19,947
19,194
18,332
18,106
18,283
18,916
17,162
17,439
18,429
19,957
18,550
19,054
20,114
21,156
26,183
29,867

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 1 0.00 2 2 0.00 2 2 2 2 2
Dividend Yield (%) 1.81 0.00 2.01 6.7 0.00 1.27 1.27 0.9 0.4 0.33

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 Jul 2025 450.95 473.15
13 Jun 2025 BONUS Bonus
1:1
13 Jun 2025 469.60 501.78
06 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Jun 2025 519.78 475.80
30 May 2025 DIVIDEND Dividend
₹ 2.00 /share
30 May 2025 543.85 491.20
28 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Apr 2025 490.60 543.85
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 426.53 433.03
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 286.40 289.20
18 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Jul 2024 246.90 281.93
12 Jul 2024 DIVIDEND Dividend
₹ 2.00 /share
11 Jul 2024 246.90 258.05
22 Jun 2023 DIVIDEND Dividend
₹ 2.00 /share
21 Jun 2023 191.85 204.38
18 Jun 2022 DIVIDEND Dividend
₹ 2.00 /share
16 Jun 2022 160.78 157.48
28 Jun 2021 DIVIDEND Dividend
₹ 2.00 /share
25 Jun 2021 126.95 125.73

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Announcement under Regulation 30 (LODR)-Credit Rating4 days ago
Clarification On Movement In PriceJul 30, 2025
Clarification sought from Vimta Labs LtdJul 29, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 21, 2025
Clarification On Volume MovementJul 21, 2025
Clarification sought from Vimta Labs LtdJul 21, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 17, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 17, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 17, 2025
Results- Financial Results Q1- 30.06.2025Jul 17, 2025
Board Meeting Outcome for Unaudited Financial Results For Quarter Ended 30Th June 2025 (Q1)Jul 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Board Meeting Intimation for The Quarter Ended 30Th June 2025 (Q1)Jul 14, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 30, 2025
Closure of Trading WindowJun 30, 2025
Complete Copy Of MOA & AOAJun 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Announcement under Regulation 30 (LODR)-AllotmentJun 14, 2025
Cancellation of Board MeetingJun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Board Meeting Intimation for Allotment Of Bonus Equity Shares.Jun 06, 2025
Revision Of Remuneration Of Executive Directors.Jun 06, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationJun 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 06, 2025
Bonus Issue Of Equity SharesJun 06, 2025
Bonus Issue - Record Date For Bonus Issue Is 13Th June 2025.Jun 06, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 06, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJun 06, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 19, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 16, 2025
Reg. 34 (1) Annual Report.May 15, 2025
Dividend - Record Date For Dividend Is 30Th May 2025.May 15, 2025
35Th Annual General Meeting Scheduled To Be Held On 06Th June 2025.May 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 10, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 28, 2025

Technical Indicators

RSI(14)
Neutral
54.25
ATR(14)
Less Volatile
43.58
STOCH(9,6)
Neutral
35.96
STOCH RSI(14)
Oversold
1.05
MACD(12,26)
Bearish
-4.66
ADX(14)
Strong Trend
28.71
UO(9)
Bearish
39.59
ROC(12)
Uptrend And Accelerating
4.03
WillR(14)
Neutral
-52.56

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.08%
-8
0.03%
0.02%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%